Hao Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hao Li has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Jiaoyang Jiang
Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin-Madison , Madison, WI 53705
6 shared publications - Baobin Li
Department of Anesthesiology, Zhongshan Hospital, Institute for Translational Brain Research, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, Fudan University, Shanghai, China
3 shared publications Matthew Worth
Department of Chemistry, University of Wisconsin-Madison, 101 University Avenue, Madison, WI, 53706, USA
3 shared publicationsChia-Wei Hu
Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin, USA
2 shared publicationsLei Lu
Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin, USA
2 shared publicationsAi M. Fletcher
1 shared publication
Latest Publications
- 1 June 2019
- Published by Elsevier in Current Opinion in Structural Biology
- Vol. 56, 97-106
Structural characterization of the O-GlcNAc cycling enzymes: insights into substrate recognition and catalytic mechanisms
- 1 June 2019
- Published by Elsevier in Current Opinion in Structural Biology
- Vol. 56, 97-106
Structural characterization of the O-GlcNAc cycling enzymes: insights into substrate recognition and catalytic mechanisms
- 12 November 2018
- Published by Wiley in ChemBioChem
- Vol. 20 (3) , 312-318
Chemical and Biochemical Strategies To Explore the Substrate Recognition of O‐GlcNAc‐Cycling Enzymes
The O‐linked N‐acetylglucosamine (O‐GlcNAc) modification is an essential component in cell regulation. A single pair of human enzymes conducts this modification dynamically on a broad variety of proteins: O‐GlcNAc transferase (OGT) adds the GlcNAc residue and O‐GlcNAcase (OGA) hydrolyzes it. This modification is dysregulated in many diseases, but its exact effect on particular substrates remains unclear. In addition, no apparent sequence motif has been found in the modified proteins, and the factors controlling the substrate specificity of OGT and OGA are largely unknown. In this minireview, we will discuss recent developments in chemical and biochemical methods toward addressing the challenge of OGT and OGA substrate recognition. We hope that the new concepts and knowledge from these studies will promote research in this area to advance understanding of O‐GlcNAc regulation in health and disease.
- 12 November 2018
- Published by Wiley in ChemBioChem
- Vol. 20 (3) , 312-318
Chemical and Biochemical Strategies To Explore the Substrate Recognition of O‐GlcNAc‐Cycling Enzymes
The O‐linked N‐acetylglucosamine (O‐GlcNAc) modification is an essential component in cell regulation. A single pair of human enzymes conducts this modification dynamically on a broad variety of proteins: O‐GlcNAc transferase (OGT) adds the GlcNAc residue and O‐GlcNAcase (OGA) hydrolyzes it. This modification is dysregulated in many diseases, but its exact effect on particular substrates remains unclear. In addition, no apparent sequence motif has been found in the modified proteins, and the factors controlling the substrate specificity of OGT and OGA are largely unknown. In this minireview, we will discuss recent developments in chemical and biochemical methods toward addressing the challenge of OGT and OGA substrate recognition. We hope that the new concepts and knowledge from these studies will promote research in this area to advance understanding of O‐GlcNAc regulation in health and disease.
- Open Access
- 23 October 2017
- Published by Springer Nature in Nature Chemical Biology
- Vol. 13 (12) , 1267-1273
Electrophilic probes for deciphering substrate recognition by O-GlcNAc transferase
N-Acetylglucosamine derivatives equipped with electrophilic groups and handles for subsequent chemical tagging are useful probes of substrate recognition by O-GlcNAc transferases and enable the capture of transient protein substrates of these enzymes. O-linked β-N-acetylglucosamine (O-GlcNAc) transferase (OGT) is an essential human glycosyltransferase that adds O-GlcNAc modifications to numerous proteins. However, little is known about the mechanism with which OGT recognizes various protein substrates. Here we report on GlcNAc electrophilic probes (GEPs) to expedite the characterization of OGT–substrate recognition. Data from mass spectrometry, X-ray crystallization, and biochemical and radiolabeled kinetic assays support the application of GEPs to rapidly report the impacts of OGT mutations on protein substrate or sugar binding and to discover OGT residues crucial for protein recognition. Interestingly, we found that the same residues on the inner surface of the N-terminal domain contribute to OGT interactions with different protein substrates. By tuning reaction conditions, a GEP enables crosslinking of OGT with acceptor substrates in situ, affording a unique method to discover genuine substrates that weakly or transiently interact with OGT. Hence, GEPs provide new strategies to dissect OGT–substrate binding and recognition.
- 23 October 2017
- Published by Springer Nature in Nature Chemical Biology
- Vol. 13 (12) , 1267-1273
Open AccessElectrophilic probes for deciphering substrate recognition by O-GlcNAc transferase
N-Acetylglucosamine derivatives equipped with electrophilic groups and handles for subsequent chemical tagging are useful probes of substrate recognition by O-GlcNAc transferases and enable the capture of transient protein substrates of these enzymes. O-linked β-N-acetylglucosamine (O-GlcNAc) transferase (OGT) is an essential human glycosyltransferase that adds O-GlcNAc modifications to numerous proteins. However, little is known about the mechanism with which OGT recognizes various protein substrates. Here we report on GlcNAc electrophilic probes (GEPs) to expedite the characterization of OGT–substrate recognition. Data from mass spectrometry, X-ray crystallization, and biochemical and radiolabeled kinetic assays support the application of GEPs to rapidly report the impacts of OGT mutations on protein substrate or sugar binding and to discover OGT residues crucial for protein recognition. Interestingly, we found that the same residues on the inner surface of the N-terminal domain contribute to OGT interactions with different protein substrates. By tuning reaction conditions, a GEP enables crosslinking of OGT with acceptor substrates in situ, affording a unique method to discover genuine substrates that weakly or transiently interact with OGT. Hence, GEPs provide new strategies to dissect OGT–substrate binding and recognition.
- Open Access
- 22 September 2017
- Published by Springer Nature in Nature Communications
- Vol. 8 (1) , 666
Structural insights into the substrate binding adaptability and specificity of human O-GlcNAcase
The O-linked β-N-acetyl glucosamine (O-GlcNAc) modification dynamically regulates the functions of numerous proteins. A single human enzyme O-linked β-N-acetyl glucosaminase (O-GlcNAcase or OGA) hydrolyzes this modification. To date, it remains largely unknown how OGA recognizes various substrates. Here we report the structures of OGA in complex with each of four distinct glycopeptide substrates that contain a single O-GlcNAc modification on a serine or threonine residue. Intriguingly, these glycopeptides bind in a bidirectional yet conserved conformation within the substrate-binding cleft of OGA. This study provides fundamental insights into a general principle that confers the substrate binding adaptability and specificity to OGA in O-GlcNAc regulation.
- 22 September 2017
- Published by Springer Nature in Nature Communications
- Vol. 8 (1) , 666
Open AccessStructural insights into the substrate binding adaptability and specificity of human O-GlcNAcase
The O-linked β-N-acetyl glucosamine (O-GlcNAc) modification dynamically regulates the functions of numerous proteins. A single human enzyme O-linked β-N-acetyl glucosaminase (O-GlcNAcase or OGA) hydrolyzes this modification. To date, it remains largely unknown how OGA recognizes various substrates. Here we report the structures of OGA in complex with each of four distinct glycopeptide substrates that contain a single O-GlcNAc modification on a serine or threonine residue. Intriguingly, these glycopeptides bind in a bidirectional yet conserved conformation within the substrate-binding cleft of OGA. This study provides fundamental insights into a general principle that confers the substrate binding adaptability and specificity to OGA in O-GlcNAc regulation.
- 20 March 2017
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 24 (4) , 362-369
Structures of human O-GlcNAcase and its complexes reveal a new substrate recognition mode
Human OGA forms an unusual arm-in-arm homodimer with a substrate-binding cleft that affords extensive interactions with the peptide substrate in a recognition mode distinct from that of its bacterial homologs. Human O-GlcNAcase (hOGA) is the unique enzyme responsible for the hydrolysis of the O-linked β-N-acetyl glucosamine (O-GlcNAc) modification, an essential protein glycosylation event that modulates the function of numerous cellular proteins in response to nutrients and stress. Here we report crystal structures of a truncated hOGA, which comprises the catalytic and stalk domains, in apo form, in complex with an inhibitor, and in complex with a glycopeptide substrate. We found that hOGA forms an unusual arm-in-arm homodimer in which the catalytic domain of one monomer is covered by the stalk domain of the sister monomer to create a substrate-binding cleft. Notably, the residues on the cleft surface afford extensive interactions with the peptide substrate in a recognition mode that is distinct from that of its bacterial homologs. These structures represent the first model of eukaryotic enzymes in the glycoside hydrolase 84 (GH84) family and provide a crucial starting point for understanding the substrate specificity of hOGA, which regulates a broad range of biological and pathological processes.
- 20 March 2017
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 24 (4) , 362-369
Structures of human O-GlcNAcase and its complexes reveal a new substrate recognition mode
Human OGA forms an unusual arm-in-arm homodimer with a substrate-binding cleft that affords extensive interactions with the peptide substrate in a recognition mode distinct from that of its bacterial homologs. Human O-GlcNAcase (hOGA) is the unique enzyme responsible for the hydrolysis of the O-linked β-N-acetyl glucosamine (O-GlcNAc) modification, an essential protein glycosylation event that modulates the function of numerous cellular proteins in response to nutrients and stress. Here we report crystal structures of a truncated hOGA, which comprises the catalytic and stalk domains, in apo form, in complex with an inhibitor, and in complex with a glycopeptide substrate. We found that hOGA forms an unusual arm-in-arm homodimer in which the catalytic domain of one monomer is covered by the stalk domain of the sister monomer to create a substrate-binding cleft. Notably, the residues on the cleft surface afford extensive interactions with the peptide substrate in a recognition mode that is distinct from that of its bacterial homologs. These structures represent the first model of eukaryotic enzymes in the glycoside hydrolase 84 (GH84) family and provide a crucial starting point for understanding the substrate specificity of hOGA, which regulates a broad range of biological and pathological processes.
- 5 January 2017
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 12 (2) , 326-335
Deciphering the Functions of Protein O-GlcNAcylation with Chemistry
O-GlcNAcylation is the modification of serine and threonine residues with β-N-acetylglucosamine (O-GlcNAc) on intracellular proteins. This dynamic modification is attached by O-GlcNAc transferase (OGT) and removed by O-GlcNAcase (OGA) and is a critical regulator of various cellular processes. Furthermore, O-GlcNAcylation is dysregulated in many diseases, such as diabetes, cancer, and Alzheimer’s disease. However, the precise role of this modification and its cycling enzymes (OGT and OGA) in normal and disease states remains elusive. This is partially due to the difficulty in studying O-GlcNAcylation with traditional genetic and biochemical techniques. In this review, we will summarize recent progress in chemical approaches to overcome these obstacles. We will cover new inhibitors of OGT and OGA, advances in metabolic labeling and cellular imaging, synthetic approaches to access homogeneous O-GlcNAcylated proteins, and cross-linking methods to identify O-GlcNAc-protein interactions. We will also discuss remaining gaps in our toolbox for studying O-GlcNAcylation and questions of high interest that are yet to be answered.
- 5 January 2017
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 12 (2) , 326-335
Deciphering the Functions of Protein O-GlcNAcylation with Chemistry
O-GlcNAcylation is the modification of serine and threonine residues with β-N-acetylglucosamine (O-GlcNAc) on intracellular proteins. This dynamic modification is attached by O-GlcNAc transferase (OGT) and removed by O-GlcNAcase (OGA) and is a critical regulator of various cellular processes. Furthermore, O-GlcNAcylation is dysregulated in many diseases, such as diabetes, cancer, and Alzheimer’s disease. However, the precise role of this modification and its cycling enzymes (OGT and OGA) in normal and disease states remains elusive. This is partially due to the difficulty in studying O-GlcNAcylation with traditional genetic and biochemical techniques. In this review, we will summarize recent progress in chemical approaches to overcome these obstacles. We will cover new inhibitors of OGT and OGA, advances in metabolic labeling and cellular imaging, synthetic approaches to access homogeneous O-GlcNAcylated proteins, and cross-linking methods to identify O-GlcNAc-protein interactions. We will also discuss remaining gaps in our toolbox for studying O-GlcNAcylation and questions of high interest that are yet to be answered.
- 1 May 2014
- Published by Elsevier in Tetrahedron
- Vol. 70 (21) , 3491-3501
Asymmetric syntheses of methyl N-Boc-2-deoxy-2-amino-l-erythroside, methyl N-Boc-2-deoxy-2-amino-d-threoside and methyl N-Boc-2,3-dideoxy-3-amino-l-arabinopyranoside
- 1 May 2014
- Published by Elsevier in Tetrahedron
- Vol. 70 (21) , 3491-3501
Asymmetric syntheses of methyl N-Boc-2-deoxy-2-amino-l-erythroside, methyl N-Boc-2-deoxy-2-amino-d-threoside and methyl N-Boc-2,3-dideoxy-3-amino-l-arabinopyranoside
- 24 July 2013
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 49 (74) , 8190-8192
Catalytic stereospecific alkylation of malononitriles with enantioenriched primary allylic amines
An unprecedented alkylation reaction of malononitriles with enantioenriched primary allylic amines has been developed in a stereospecific manner through palladium-catalyzed sp3 C–N bond cleavage without additives at room temperature.
- 24 July 2013
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 49 (74) , 8190-8192
Catalytic stereospecific alkylation of malononitriles with enantioenriched primary allylic amines
An unprecedented alkylation reaction of malononitriles with enantioenriched primary allylic amines has been developed in a stereospecific manner through palladium-catalyzed sp3 C–N bond cleavage without additives at room temperature.